"The ability to correct disease-causing mutations is one of the primary goals of genome editing,” said the Broad Institute’s Feng Zhang. “So far, we’ve gotten very good at inactivating genes, but actually recovering lost protein function is much more challenging. This new ability to edit RNA opens up more potential opportunities to recover that function and treat many diseases, in almost any kind of cell.”